Answers are grounded in this paper and cite their sources.
In a randomized placebo crossover controlled study, six patients meeting DSM-III-R criteria for Alzheimer's disease and exhibiting significantly aggressive behaviour were administered carbamazepine (in doses up to 600 mg daily) and placebo, with each treatment period lasting 8 weeks. Levels of aggression as measured by the RAGE scale were significantly reduced compared with placebo (p<0.05). The results suggest that carbamazepine is an effective anti-aggressive agent in patients with dementia. Recommendations for further studies are made.
No takes yet. Share an insight, caveat, or question.
Cooney et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: